U 46619Cat No. 1932 |
Price and Availability |
|
Alternative Name: 9,11-Dideoxy-9 Chemical Name: (5Z)-7-[(1R,4S,5S,6R)-6-[(1E,3S)-3-Hydroxy-1-octenyl]-2 -oxabicyclo[2.2.1]hept-5-yl]-5-heptenoic acid |
|
Biological Activity
PGH2 (TXA2) analog that is a potent and stable thromboxane A2 (TP) receptor agonist (EC50 = 0.035 μM). Potently stimulates TP receptor-mediated, but not other prostaglandin receptor-mediated responses in various in vitro preparations. Activates ERK-1 and ERK-2 in HEK-293 cells expressing TPα and TPβ receptors.Technical Data
M.Wt:The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis and MSDS.
Resources
Certificate of Analysis / MSDS
References
Coleman et al (1981) Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br.J.Pharmacol. 73 773. Morinelli et al (1987) Receptor-mediated effects of a PGH2 analogue (U 46619) on human platelets. Am.J.Physiol. 253 H1035. Miggin and Kinsella (2002) Regulation of extracellular signal-regulated kinase cascades by a- and b-isoforms of the human thromboxane A2 receptor. Mol.Pharmacol. 61 817.If you know of a useful citation for this product please let us know.
View Related Products by Target
Keywords: U 46619, Potent, stable, thromboxane, A2, TP, receptor, agonists, TXA2, Prostanoid, prostaglandins, prostacyclins, eicosanoids, U46619, 9, 11-Dideoxy-9a, 11a-methanoepoxy, prostaglandinF2a
Buy Now / Print Quote
Find multiple products by catalog number
New Products in this Area
Selective P2Y6 agonist
NF 340Selective P2Y11 antagonist
Ticlopidine hydrochlorideSelective P2Y12 antagonist
VU 152100Positive allosteric modulator of M4 receptors
CYM 5442 hydrochlorideSelective S1P1 receptor agonist
SC 51322Potent EP1 receptor antagonist
MRS 2768 tetrasodium saltSelective P2Y2 agonist
Careers at Tocris
Tocris Bioscience currently has opportunities for a Chemistry Technician.
If you would like to be considered for any positions not currently advertised, we welcome your speculative application.







